Corrections India’s health ministry bans pioglitazone, metamizole, and flupentixol-melitracen BMJ 2015; 350 doi: https://doi.org/10.1136/bmj.h1232 (Published 04 March 2015) Cite this as: BMJ 2015;350:h1232 Article Related content Metrics Responses Peer review Related articles News India’s health ministry bans pioglitazone, metamizole, and flupentixol-melitracen Published: 05 July 2013; BMJ 347 doi:10.1136/bmj.f4366 See more Salah Sorour BMJ May 27, 2022, 377 o1352; DOI: https://doi.org/10.1136/bmj.o1352 Covid-19: Suicide rates fell during Brazil’s first wave but increased in older people BMJ May 27, 2022, 377 o1351; DOI: https://doi.org/10.1136/bmj.o1351 GMC to review Manjula Arora case after backlash from doctors BMJ May 27, 2022, 377 o1350; DOI: https://doi.org/10.1136/bmj.o1350 Stephen Furniss BMJ May 27, 2022, 377 o1317; DOI: https://doi.org/10.1136/bmj.o1317 Child protection services: Review calls for overhaul after deaths of two children BMJ May 27, 2022, 377 o1349; DOI: https://doi.org/10.1136/bmj.o1349
